| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
| filingDate |
2011-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0362b3674dec78323d8a3a030e42e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed011f2169ea4407d4d97a8e9767419a |
| publicationDate |
2011-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011201130-A1 |
| titleOfInvention |
Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms |
| abstract |
The present disclosure provides among other things assays, methods and kits for assessing the presence or amount of human B-type natriuretic peptide in a test sample wherein the assay exhibits reduced cross-reactivity with other forms of the peptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018089539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015027206-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022126129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021231208-A1 |
| priorityDate |
2007-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |